Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.42 - April 2017 - Cannabis policy in the Americas
Auteur(s) :
A. STEVENS, Éditeur scientifique ;
R. L. PACULA, Éditeur scientifique ;
ISSDP
Paru le :
01/04/2017
Article en page(s) :
1-120
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
SAN (Santé publique / Public health)
Note de contenu :
CONTENTS:
- High risk injecting behaviour among people who inject pharmaceutical opioids in Australia. Iversen J., Dertadian G., Geddes L., Maher L., p. 1-6.
- Non-violent threats and promises among closed-market drug dealers. Dickinson T., p. 7-14.
- Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? Sznitman S.R., p. 15-21.
- Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. Hochstatter K.R., Hull S.J., Stockman L.J., Stephens L.K., Olson-Streed H.K., Ehlenbach W.J., et al., p. 22-25.
- Beyond joints and brownies: Marijuana concentrates in the legal landscape of WA State. Carlini B.H., Garrett S.B., Harwick R.M., p. 26-29.
- Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Lucas P., Walsh Z., p. 30-35.
- Advancing knowledge on cannabis policy using evidence from North America [Editorial]. Stevens A., Pacula R.L., p. 36-38.
- Building smart cannabis policy from the science up. Weiss S.R.B., Howlett K.D., Baler R.D., p. 39-49.
- Recognizing and regulating cannabis as a temptation good. Caulkins J.P., p. 50-56.
- Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes. Hall W., p. 57-62.
- High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Lake S., Kerr T., Capler R., Shoveller J., Montaner J., Milloy M.J., p. 63-70.
- A practical framework for regulating for-profit recreational marijuana in US States: Lessons from Colorado and Washington. Carnevale J.T., Kagan R., Murphy P.J., Esrick J., p. 71-85.
- Into the void: Regulating pesticide use in Colorado's commercial cannabis markets. Subritzky T., Pettigrew S., Lenton S., p. 86-96.
- From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada. Bear D., p. 97-101.
- Community-level policy responses to state marijuana legalization in Washington State. Dilley J.A., Hitchcock L., McGroder N., Greto L.A., Richardson S.M., p. 102-108.
- Observations of the role of science in the United States medical cannabis state policies: Lessons learnt. Grbic J., Goddard P., Ryder D., p. 109-114.
- The implementation of medical ganja in Jamaica. Jones S., Porter R., Bishop C., p. 115-117.
- Uruguay's middle-ground approach to cannabis legalization. Cerda M., Kilmer B., p. 118-120.
- High risk injecting behaviour among people who inject pharmaceutical opioids in Australia. Iversen J., Dertadian G., Geddes L., Maher L., p. 1-6.
- Non-violent threats and promises among closed-market drug dealers. Dickinson T., p. 7-14.
- Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? Sznitman S.R., p. 15-21.
- Using database linkages to monitor the continuum of care for hepatitis C virus among syringe exchange clients: Experience from a pilot intervention. Hochstatter K.R., Hull S.J., Stockman L.J., Stephens L.K., Olson-Streed H.K., Ehlenbach W.J., et al., p. 22-25.
- Beyond joints and brownies: Marijuana concentrates in the legal landscape of WA State. Carlini B.H., Garrett S.B., Harwick R.M., p. 26-29.
- Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Lucas P., Walsh Z., p. 30-35.
- Advancing knowledge on cannabis policy using evidence from North America [Editorial]. Stevens A., Pacula R.L., p. 36-38.
- Building smart cannabis policy from the science up. Weiss S.R.B., Howlett K.D., Baler R.D., p. 39-49.
- Recognizing and regulating cannabis as a temptation good. Caulkins J.P., p. 50-56.
- Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes. Hall W., p. 57-62.
- High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Lake S., Kerr T., Capler R., Shoveller J., Montaner J., Milloy M.J., p. 63-70.
- A practical framework for regulating for-profit recreational marijuana in US States: Lessons from Colorado and Washington. Carnevale J.T., Kagan R., Murphy P.J., Esrick J., p. 71-85.
- Into the void: Regulating pesticide use in Colorado's commercial cannabis markets. Subritzky T., Pettigrew S., Lenton S., p. 86-96.
- From Toques to Tokes: Two challenges facing nationwide legalization of cannabis in Canada. Bear D., p. 97-101.
- Community-level policy responses to state marijuana legalization in Washington State. Dilley J.A., Hitchcock L., McGroder N., Greto L.A., Richardson S.M., p. 102-108.
- Observations of the role of science in the United States medical cannabis state policies: Lessons learnt. Grbic J., Goddard P., Ryder D., p. 109-114.
- The implementation of medical ganja in Jamaica. Jones S., Porter R., Bishop C., p. 115-117.
- Uruguay's middle-ground approach to cannabis legalization. Cerda M., Kilmer B., p. 118-120.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
J. IVERSEN ;
G. DERTADIAN ;
L. GEDDES ;
L. MAHER
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Background: Use of opioid analgesic medicines has doubled globally over the past decade, with a concomitant increase in prevalence of injection of pharmaceutical opioids (PO), including in Australia. This study investigates types of PO injected,[...]
Nouveauté
T. DICKINSON
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Background: An unintended consequence of drug prohibitions is that they often fail to absolutely deter potential drug dealers and users and instead restrictively deter them. One way in which dealers sometimes alter their behaviour in response to[...]
Nouveauté
S. R. B. WEISS ;
K. D. HOWLETT ;
R. D. BALER
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Social attitudes and cultural norms around the issue of substance abuse are shifting rapidly around the world, leading to complex and unpredictable consequences. On the positive side, efforts to more intensely disseminate the scientific evidence[...]
Nouveauté
J. P. CAULKINS
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
The U.S. appears to be on a path toward legalizing cannabis on the alcohol model, which is to say allowing for-profit corporations to produce, sell, and promote its use. Even after national legalization, it will take decades to observe the full [...]
Nouveauté
The claim that the adverse health effects of cannabis are much less serious than those of alcohol has been central to the case for cannabis legalisation. Regulators in US states that have legalised cannabis have adopted regulatory models based o[...]
Nouveauté
J. T. CARNEVALE ;
R. KAGAN ;
P. J. MURPHY ;
J. ESRICK
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Despite the federal prohibition against marijuana, state-level recreational use appears to be moving forward. Public opinion is shifting. Following well-publicized state-legalization in Washington and Colorado, states across the US have begun co[...]
Nouveauté
Background: In 2015, a new Liberal Government came to power in Canada, elected on a platform that included legalization and regulation of cannabis for recreational purposes. Their legislation, based on recommendations from a Federal Task Force o[...]
Nouveauté
J. A. DILLEY ;
L. HITCHCOCK ;
N. MCGRODER ;
L. A. GRETO ;
S. M. RICHARDSON
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Background: Washington State (WA) legalized a recreational marijuana market - including growing, processing and retail sales - through voter initiative 502 in November 2012. Legalized recreational marijuana retail sales began in July 2014.
In r[...]
Nouveauté
J. GRBIC ;
P. GODDARD ;
D. RYDER
|
2017
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.42, April 2017) Article : Périodique
Background: Clinical trials have shown cannabis to be effective in the treatment of some medical conditions and there is mounting public and political pressure to enact laws enabling the use of cannabis for medicinal purposes. To date, 28 United[...]